Preclinical Evaluation of M002, a Novel Oncolytic Herpes Simplex Virus, in Fusion-Positive Rhabdomyosarcoma

Grant

Awarded By

Total Award Amount

  • 100000.00

    • Direct Costs

  • 100000.00

    • Sponsor Award Id

    • Contributor

  • Elizabeth Beierle Chen M.D.   Principal Investigator  
  • Jamie Aye   Investigator